ERAS and Tubeless—Michael Haddock: the past and future of proton beam
Meet The Professor
Dr. Charles M. Balch, M.D., FACS, Professor of Surgery, University of Texas Southwestern Medical Center, prior Deputy Director for Clinical Trials and Outcomes Research at Johns Hopkins Institute and Executive Vice President and Chief Executive Officer of American Society of Clinical Oncology (ASCO), enjoys a worldwide reputation for his distinguished career as a clinical and academic oncologist for the past 35 years and a leading authority in both melanoma and breast cancer.
Sandra M. Swain, MD, the current president of American Society of Clinical Oncology (ASCO), holds an international reputation as one of the America’s Leading Experts on Adjuvant Chemotherapy & Breast Cancer (Breast Neoplasm) and the leading authority both in the emergent field of inflammatory breast cancer treatment and in the treatment of early breast cancer with 28 years of medical experience and practice in Medical Oncology.
Dr. Peter Yu, the succeeding President of American Society of Clinical Oncology 2014-2015, is a Hematologist and Medical Oncologist at the Hematology-Oncology Department of the Palo Alto Medical Foundation and Director of Cancer Research.
Chinese Clinical Oncology (CCO) interviewed Dr. Rik, the immunologist and experimental pathologist in the Department of Pathology of VUmc in Amsterdam at the 2011 CSCO meeting in Beijing where he give us some comments on the regulations of cell therapy in Europe.
Daniel J. Sargent, Ph.D., Professor of Oncology, Professor of Biostatistics and Director of Cancer Center Statistics of Mayo Clinic Cancer Center, Rochester, MN, USA, informed Chinese Clinical Oncology (CCO) of his past working experience related to clinical trials and databases collaboration like ACCENT and his project of the new co-authored column in CCO.
At the 16th Annual Meeting of Chinese Society of Clinical Oncology (CSCO), Prof. Shukui Qin, the executive member of ACOS and the chairman of CSCO, informed Chinese Clinical Oncology (CCO) of his professional view on Strategy on liver cancer treatment for Asian population.
Jean-Pierre Armand MD, MSc, certified in Medical Oncology, is active as a senior consultant at Institute Gustave Roussy and Institute Curie in Paris.
Dr. Claus-Henning Koehne, Chairman of the Department of Hematology and Oncology, Klinikum Oldenburg, Germany, is an internationally renowned prolific and outstanding oncologist and hematologist.